93 related articles for article (PubMed ID: 2043377)
1. [Successful treatment of incontinence of feces in myotonic muscular dystrophy by mexiletine].
Hayashi T; Ichiyama T; Tanaka H; Koga M; Okino A
No To Hattatsu; 1991 May; 23(3):310-2. PubMed ID: 2043377
[No Abstract] [Full Text] [Related]
2. Procainamide for faecal incontinence in myotonic dystrophy.
Pelliccioni G; Scarpino O; Piloni V
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):257-8. PubMed ID: 10475766
[No Abstract] [Full Text] [Related]
3. Cardiovascular effects of mexiletine for treatment of myotonia in myotonic dystrophy type 1.
Salguero-Bodes R; Ruiz-Curiel A; Palomino-Doza J; Valverde-Gómez M; Domínguez-González C; Arribas-Ynsaurriaga F
Rev Esp Cardiol (Engl Ed); 2021 Nov; 74(11):986-987. PubMed ID: 34120884
[No Abstract] [Full Text] [Related]
4. The prevalence of faecal incontinence in myotonic dystrophy type 1.
Petty RKH; Eugenicos MP; Hamilton MJ; Farrugia ME; Robb Y; Ballantyne R; Gregory H; McWilliam C; Longman C
Neuromuscul Disord; 2019 Jul; 29(7):562-566. PubMed ID: 31266721
[TBL] [Abstract][Full Text] [Related]
5. Faecal incontinence in myotonic dystrophy.
Abercrombie JF; Rogers J; Swash M
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):128-30. PubMed ID: 9436743
[TBL] [Abstract][Full Text] [Related]
6. Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy.
Wahbi K; Bassez G; Duchateau J; Salort-Campana E; Vicart S; Desaphy JF; Labombarda F; Sellal JM; Deharo JC
Arch Cardiovasc Dis; 2024; 117(6-7):450-456. PubMed ID: 38677940
[TBL] [Abstract][Full Text] [Related]
7. Faecal incontinence due to atrophy of the anal sphincter in myotonic dystrophy: a case report.
Degraeuwe J; Van Laecke E; De Muynck M; Van Biervliet S; Vande Velde S; Van Winckel M
Acta Gastroenterol Belg; 2011 Mar; 74(1):88-90. PubMed ID: 21563659
[TBL] [Abstract][Full Text] [Related]
8. Lower gastrointestinal tract disturbance in congenital myotonic dystrophy.
Kerr TP; Robb SA; Clayden GS
Eur J Pediatr; 2002 Aug; 161(8):468-9. PubMed ID: 12269262
[No Abstract] [Full Text] [Related]
9. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.
Heatwole C; Luebbe E; Rosero S; Eichinger K; Martens W; Hilbert J; Dekdebrun J; Dilek N; Zizzi C; Johnson N; Puwanant A; Tawil R; Schifitto G; Beck CA; Richeson JF; Zareba W; Thornton C; McDermott MP; Moxley R
Neurology; 2021 Jan; 96(2):e228-e240. PubMed ID: 33046619
[TBL] [Abstract][Full Text] [Related]
10. [The problem of diagnosis and therapy of myotonic dystrophy].
Reisecker F; Markut H; Tulzer W
Wien Med Wochenschr; 1983 Jun; 133(12):319-21. PubMed ID: 6613149
[TBL] [Abstract][Full Text] [Related]
11. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy type 1.
Nguyen CE; Campbell C
CMAJ; 2016 Oct; 188(14):1033. PubMed ID: 27270116
[No Abstract] [Full Text] [Related]
13. Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy.
Lidonnici D; Brambilla P; Ravasio R; Zozulya-Weidenfeller A; Beiderbeck A; van Aswegen M; Oliveira R; Sansone VA
J Neuromuscul Dis; 2024; 11(2):411-423. PubMed ID: 38306059
[TBL] [Abstract][Full Text] [Related]
14. To the Editor-Mexiletine in myotonic dystrophy: Beware of ventricular arrhythmias!
Gutiérrez-Ballesteros G; Bermúdez-Jiménez FJ; Jiménez-Jáimez J
Heart Rhythm; 2021 Apr; 18(4):660. PubMed ID: 33346138
[No Abstract] [Full Text] [Related]
15. Reply to the Editor-Mexiletine in myotonic dystrophy: Beware of ventricular arrhythmias!
Vio R; Zorzi A; Corrado D; Calore C
Heart Rhythm; 2021 Apr; 18(4):660-661. PubMed ID: 33346137
[No Abstract] [Full Text] [Related]
16. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Groh WJ
Neurology; 2011 Jan; 76(4):409; author reply 409. PubMed ID: 21263144
[No Abstract] [Full Text] [Related]
17. A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
Eroğlu S; Ozin B; Ozbiçer S; Müderrisoğlu H
Turk Kardiyol Dern Ars; 2009 Jul; 37(5):337-40. PubMed ID: 19875908
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological therapies for muscular dystrophies.
Abdel-Hamid H; Clemens PR
Curr Opin Neurol; 2012 Oct; 25(5):604-8. PubMed ID: 22941265
[TBL] [Abstract][Full Text] [Related]
19. Impact of restricted access to, and low awareness of, mexiletine on people with myotonia: a real-world European survey.
Díaz-Manera J; Urtizberea JA; Schey C; Kole A; von Gallwitz P; Whiting A; Foerster D; Zozulya-Weidenfeller A
Neuromuscul Disord; 2023 Feb; 33(2):208-217. PubMed ID: 36706619
[TBL] [Abstract][Full Text] [Related]
20. Gastric bezoar in a patient with myotonic dystrophy. A review of the gastrointestinal complications of myotonic dystrophy.
Kuiper DH
Am J Dig Dis; 1971 Jun; 16(6):529-34. PubMed ID: 5089542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
